Antigonadotropic effect of high doses cyproterone acetate

封面


如何引用文章

全文:

详细

Objective. To study the therapeutic effect of antiandrogenic preparation Androcur (cyproterone acetate) in patients with severe hirsutism.

全文:

Objective. To study the therapeutic effect of antiandrogenic preparation Androcur (cyproterone acetate) in patients with severe hirsutism.

Methods. FSH, LH and testosterone levels were determined in blood of 36patients. Androcur containing 10 and 50 mg cyproterone acetate (CA) was used for the treatment.

Results. A significant decrease of FSH, LH and testosterone blood levels was observed as soon as in 3 months of using 50-100 mg of CA, while CA in a dose of 10 mg resulted in a significant decrease of FSH, LH levels only after 6-month treatment. Antigonadotropic and antiandrogenic effects developed earlier and were more pronounced at the dose of CA 50-100 mg, and after 9 moths of treatment LH levels decreased from 6.8±1.6 to 0.3±0. ILU/l (p<0.001). At the same time no reliable differences were found in the hirsutism dynamics in both groups of patients.

Conclusion. The rise of CA dose is followed by the increase of antigonadotropic and antiandrogenic effect of Androcur. High doses (50-100 mg) CA are advisable to be used in cases of severe hyperandrogenemy and patients with polycistic ovary syndrome.

×

作者简介

E. Soboleva

D.O. Ott Institute of Obstetrics and Gynecology, Russian Academy of Medical Sciences

编辑信件的主要联系方式.
Email: info@eco-vector.com
俄罗斯联邦, St. Petersburg

V. Poteen

D.O. Ott Institute of Obstetrics and Gynecology, Russian Academy of Medical Sciences

Email: info@eco-vector.com
俄罗斯联邦, St. Petersburg

参考

补充文件

附件文件
动作
1. JATS XML

版权所有 © Eсо-Vector, 1999



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 66759 от 08.08.2016 г. 
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия Эл № 77 - 6389
от 15.07.2002 г.